David J. Posey

14.0k total citations
72 papers, 4.7k citations indexed

About

David J. Posey is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Clinical Psychology. According to data from OpenAlex, David J. Posey has authored 72 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Cognitive Neuroscience, 56 papers in Psychiatry and Mental health and 23 papers in Clinical Psychology. Recurrent topics in David J. Posey's work include Autism Spectrum Disorder Research (62 papers), Attention Deficit Hyperactivity Disorder (39 papers) and Child Nutrition and Feeding Issues (19 papers). David J. Posey is often cited by papers focused on Autism Spectrum Disorder Research (62 papers), Attention Deficit Hyperactivity Disorder (39 papers) and Child Nutrition and Feeding Issues (19 papers). David J. Posey collaborates with scholars based in United States, Japan and Czechia. David J. Posey's co-authors include Christopher J. McDougle, Kimberly A. Stigler, Craig A. Erickson, Thayne L. Sweeten, Benedetto Vitiello, James T. McCracken, Naomi B. Swiezy, Elaine Tierney, Lawrence David Scahill and Michael G. Aman and has published in prestigious journals such as Journal of Clinical Investigation, American Journal of Psychiatry and PEDIATRICS.

In The Last Decade

David J. Posey

71 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Posey United States	46	3.6k	2.9k	1.3k	1.2k	474	72	4.7k
Elaine Tierney United States	39	3.4k 0.9×	2.0k 0.7×	1.5k 1.2×	1.6k 1.3×	492 1.0×	68	4.7k
Benjamin L. Handen United States	39	2.7k 0.7×	2.7k 0.9×	1.5k 1.1×	618 0.5×	682 1.4×	176	4.5k
Susan Hyman United States	34	2.1k 0.6×	1.5k 0.5×	1.1k 0.9×	673 0.6×	296 0.6×	72	3.7k
Linmarie Sikich United States	28	1.5k 0.4×	1.8k 0.6×	988 0.8×	571 0.5×	273 0.6×	67	3.4k
Keun‐Ah Cheon South Korea	26	2.2k 0.6×	1.3k 0.5×	964 0.7×	644 0.5×	260 0.5×	91	3.3k
Paramala Santosh United Kingdom	32	1.8k 0.5×	2.6k 0.9×	1.0k 0.8×	404 0.3×	493 1.0×	109	3.9k
Cristan Farmer United States	36	1.8k 0.5×	1.1k 0.4×	1.2k 1.0×	600 0.5×	336 0.7×	125	3.4k
Rosalind J. Neuman United States	39	1.2k 0.3×	1.9k 0.7×	1.3k 1.0×	787 0.7×	234 0.5×	91	4.7k
Magda Campbell United States	36	1.8k 0.5×	2.5k 0.9×	1.8k 1.4×	497 0.4×	450 0.9×	81	3.7k
Raun D. Melmed United States	26	1.4k 0.4×	954 0.3×	722 0.6×	784 0.7×	205 0.4×	40	2.6k

Countries citing papers authored by David J. Posey

Since Specialization

Citations

This map shows the geographic impact of David J. Posey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Posey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Posey more than expected).

Fields of papers citing papers by David J. Posey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Posey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Posey. The network helps show where David J. Posey may publish in the future.

Co-authorship network of co-authors of David J. Posey

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Posey. A scholar is included among the top collaborators of David J. Posey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Posey. David J. Posey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McDougle, Christopher J., Robyn P. Thom, Caitlin Ravichandran, et al.. (2022). A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorder. Neuropsychopharmacology. 47(6). 1263–1270. 15 indexed citations

Wink, Logan, Noha F. Minshawi, Rebecca C. Shaffer, et al.. (2017). d-Cycloserine enhances durability of social skills training in autism spectrum disorder. Molecular Autism. 8(1). 2–2. 34 indexed citations

Wink, Logan, Ryan Adams, Zemin Wang, et al.. (2016). A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder. PMC.

Minshawi, Noha F., Logan Wink, Rebecca C. Shaffer, et al.. (2016). A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders. Molecular Autism. 7(1). 2–2. 53 indexed citations

Erickson, Craig A., Kimberly A. Stigler, Logan Wink, et al.. (2011). A prospective open-label study of aripiprazole in fragile X syndrome. Psychopharmacology. 216(1). 85–90. 51 indexed citations

Arnold, L. Eugene, Cristan Farmer, Helena C. Kraemer, et al.. (2010). Moderators, Mediators, and Other Predictors of Risperidone Response in Children with Autistic Disorder and Irritability. Journal of Child and Adolescent Psychopharmacology. 20(2). 83–93. 46 indexed citations

Erickson, Craig A., Kimberly A. Stigler, David J. Posey, & Christopher J. McDougle. (2010). Aripiprazole in Autism Spectrum Disorders and Fragile X Syndrome. Neurotherapeutics. 7(3). 258–263. 55 indexed citations

Stigler, Kimberly A., Arlene E. Kohn, Lang Li, et al.. (2009). Aripiprazole in Pervasive Developmental Disorder Not Otherwise Specified and Asperger's Disorder: A 14-Week, Prospective, Open-Label Study. Journal of Child and Adolescent Psychopharmacology. 19(3). 265–274. 72 indexed citations

Aman, Michael G., Jill A. Hollway, Christopher J. McDougle, et al.. (2008). Cognitive Effects of Risperidone in Children with Autism and Irritable Behavior. Journal of Child and Adolescent Psychopharmacology. 18(3). 227–236. 49 indexed citations

10.

Erickson, Craig A., David J. Posey, Kimberly A. Stigler, & Christopher J. McDougle. (2007). Pharmacologic Treatment of Autism and Related Disorders. Pediatric Annals. 36(9). 575–585. 15 indexed citations

11.

Posey, David J. & Christopher J. McDougle. (2007). Guanfacine and Guanfacine Extended Release: Treatment for ADHD and Related Disorders. CNS Drug Reviews. 13(4). 465–474. 24 indexed citations

12.

Posey, David J., Craig A. Erickson, Kimberly A. Stigler, & Christopher J. McDougle. (2006). The Use of Selective Serotonin Reuptake Inhibitors in Autism and Related Disorders. Journal of Child and Adolescent Psychopharmacology. 16(1-2). 181–186. 49 indexed citations

13.

Anderson, George M., Lawrence David Scahill, James T. McCracken, et al.. (2006). Effects of Short- and Long-Term Risperidone Treatment on Prolactin Levels in Children with Autism. Biological Psychiatry. 61(4). 545–550. 124 indexed citations

14.

Stigler, Kimberly A., et al.. (2004). A Naturalistic Retrospective Analysis of Psychostimulants in Pervasive Developmental Disorders. Journal of Child and Adolescent Psychopharmacology. 14(1). 49–56. 58 indexed citations

15.

Stigler, Kimberly A., David J. Posey, & Christopher J. McDougle. (2004). Aripiprazole for Maladaptive Behavior in Pervasive Developmental Disorders. Journal of Child and Adolescent Psychopharmacology. 14(3). 455–463. 77 indexed citations

16.

Posey, David J., et al.. (2004). Guanfacine Treatment of Hyperactivity and Inattention in Pervasive Developmental Disorders: A Retrospective Analysis of 80 Cases. Journal of Child and Adolescent Psychopharmacology. 14(2). 233–241. 90 indexed citations

17.

Sweeten, Thayne L., David J. Posey, Anantha Shekhar, & Christopher J. McDougle. (2002). The amygdala and related structures in the pathophysiology of autism. Pharmacology Biochemistry and Behavior. 71(3). 449–455. 79 indexed citations

18.

McDougle, Christopher J., et al.. (2002). Case Series: Use of Ziprasidone for Maladaptive Symptoms in Youths With Autism. Journal of the American Academy of Child & Adolescent Psychiatry. 41(8). 921–927. 108 indexed citations

19.

McDougle, Christopher J. & David J. Posey. (2002). Genetics of Childhood Disorders: XLIV. Autism, Part 3: Psychopharmacology of Autism. Journal of the American Academy of Child & Adolescent Psychiatry. 41(11). 1380–1383. 22 indexed citations

20.

Arnold, L. Eugene, M. G. Aman, Andrés Martin, et al.. (2000). Assessment in Multisite Randomized Clinical Trials of Patients with Autistic Disorder: The Autism RUPP Network. Journal of Autism and Developmental Disorders. 30(2). 99–111. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact